Groundbreaking research shows that as men age, harmful genetic mutations in sperm become more common—not just from random ...

Pharmacists are integral to oncology care, optimizing treatment plans, managing adverse effects, and supporting precision medicine through collaborative practice agreements.

Biomarker testing helps identify effective targeted therapies and avoid those that are less likely to work in certain ...

EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens ...

In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...

QIAGEN N.V. today announced the launch of the EZ2 DNA Investigator Sep&Prep Kit, a fully automated solution for processing sexual assault samples, at the upcoming International Symposium on Human ...

Scientists at Virginia Tech's Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer immunotherapy with back-to-back review articles published in ...

In this interview, we explore how single-cell technologies, automation and strategic partnerships are shaping the future of cancer immunotherapy.

DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker ...

Cleared by the FDA in 2024, the test gained real-world traction in 2025 when it was incorporated into a new global framework ...